FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 125 filers reported holding FATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $33,691 | +320.1% | 4,590 | +114.1% | 0.00% | – |
| Q4 2023 | $8,019 | -16.4% | 2,144 | -52.6% | 0.00% | – |
| Q3 2023 | $9,593 | -55.5% | 4,525 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $21,539 | -16.5% | 4,525 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $25,793 | -48.6% | 4,525 | -9.0% | 0.00% | -50.0% |
| Q4 2022 | $50,167 | -55.0% | 4,972 | 0.0% | 0.00% | -60.0% |
| Q3 2022 | $111,423 | -9.6% | 4,972 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $123,206 | -36.1% | 4,972 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $192,764 | -84.3% | 4,972 | -76.3% | 0.01% | -58.8% |
| Q4 2021 | $1,227,481 | -5.2% | 20,979 | -4.0% | 0.02% | -10.5% |
| Q3 2021 | $1,294,694 | -31.0% | 21,844 | +1.1% | 0.02% | -26.9% |
| Q2 2021 | $1,875,185 | +12.4% | 21,606 | +6.7% | 0.03% | +4.0% |
| Q1 2021 | $1,669,035 | -8.0% | 20,243 | +1.5% | 0.02% | -7.4% |
| Q4 2020 | $1,813,599 | +118.4% | 19,945 | -4.0% | 0.03% | +80.0% |
| Q3 2020 | $830,297 | +26.6% | 20,773 | +8.7% | 0.02% | +25.0% |
| Q2 2020 | $655,870 | +60.2% | 19,116 | +3.7% | 0.01% | +33.3% |
| Q1 2020 | $409,330 | +6.7% | 18,430 | -6.0% | 0.01% | +50.0% |
| Q4 2019 | $383,572 | +26.0% | 19,600 | 0.0% | 0.01% | +20.0% |
| Q3 2019 | $304,388 | -26.6% | 19,600 | -4.0% | 0.01% | -28.6% |
| Q2 2019 | $414,587 | +15.5% | 20,423 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $358,832 | +36.9% | 20,423 | 0.0% | 0.01% | +40.0% |
| Q4 2018 | $262,027 | -2.3% | 20,423 | +24.0% | 0.01% | 0.0% |
| Q3 2018 | $268,247 | -99.9% | 16,467 | 0.0% | 0.01% | +66.7% |
| Q2 2018 | $186,736,000 | +21.1% | 16,467 | +4.2% | 0.00% | +50.0% |
| Q1 2018 | $154,198,000 | – | 15,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $75,725,000 | 22.28% |
| Redmile Group, LLC | 12,957,222 | $290,371,000 | 11.26% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $23,245,000 | 5.51% |
| DAFNA Capital Management LLC | 539,940 | $12,100,000 | 3.25% |
| Casdin Capital, LLC | 2,050,000 | $45,941,000 | 3.02% |
| Artal Group S.A. | 2,600,000 | $58,266,000 | 2.49% |
| ARK Investment Management | 11,655,833 | $261,207,000 | 1.82% |
| HighVista Strategies LLC | 111,545 | $2,500,000 | 1.43% |
| Deep Track Capital, LP | 1,311,113 | $29,382,000 | 1.35% |
| Octagon Capital Advisors LP | 331,096 | $7,420,000 | 1.28% |